
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Etomidate Attenuates the Ferroptosis in Myocardial Ischemia/Reperfusion Rat Model via Nrf2/HO-1 Pathway
Zhenqian Lv, Feng’e Wang, Xingfeng Zhang, et al.
Shock (2021) Vol. 56, Iss. 3, pp. 440-449
Open Access | Times Cited: 65
Zhenqian Lv, Feng’e Wang, Xingfeng Zhang, et al.
Shock (2021) Vol. 56, Iss. 3, pp. 440-449
Open Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
Lai‐Hua Xie, Nadezhda Fefelova, Sri Harika Pamarthi, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2726-2726
Open Access | Times Cited: 94
Lai‐Hua Xie, Nadezhda Fefelova, Sri Harika Pamarthi, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2726-2726
Open Access | Times Cited: 94
High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2-Mediated Autophagy Dysfunction and Ferroptosis
Wei Yu, Weidong Liu, De Xie, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 78
Wei Yu, Weidong Liu, De Xie, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 78
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Wenxi Fang, Saiyang Xie, Wei Deng
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 13
Wenxi Fang, Saiyang Xie, Wei Deng
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 13
Emerging roles of ferroptosis in cardiovascular diseases
Kai Wang, Xinzhe Chen, Yunhong Wang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Kai Wang, Xinzhe Chen, Yunhong Wang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
Yihang Pan, Xueke Wang, Xiwang Liu, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2196-2196
Open Access | Times Cited: 57
Yihang Pan, Xueke Wang, Xiwang Liu, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2196-2196
Open Access | Times Cited: 57
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Life Sciences (2022) Vol. 300, pp. 120561-120561
Closed Access | Times Cited: 45
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Life Sciences (2022) Vol. 300, pp. 120561-120561
Closed Access | Times Cited: 45
Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury
Jun Zhang, Wanqian Pan, Yue Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6626-6645
Open Access | Times Cited: 41
Jun Zhang, Wanqian Pan, Yue Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6626-6645
Open Access | Times Cited: 41
Ferroptosis: A double-edged sword
Shengmei Wang, Qiuyan Guo, Lili Zhou, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Shengmei Wang, Qiuyan Guo, Lili Zhou, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia–reperfusion injury
Chen-Hua Zhang, Yujie Yan, Qi Luo
Life Sciences (2024) Vol. 340, pp. 122439-122439
Open Access | Times Cited: 12
Chen-Hua Zhang, Yujie Yan, Qi Luo
Life Sciences (2024) Vol. 340, pp. 122439-122439
Open Access | Times Cited: 12
Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis
Sijie Jin, He Wang, Xiaohao Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116457-116457
Open Access | Times Cited: 9
Sijie Jin, He Wang, Xiaohao Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116457-116457
Open Access | Times Cited: 9
Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 9
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 9
Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored
Fangze Huang, Ronghua Yang, Zezhou Xiao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 40
Fangze Huang, Ronghua Yang, Zezhou Xiao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 40
The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction
Kyoko Komai, Nicholas K. Kawasaki, Jason K. Higa, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1399-1399
Open Access | Times Cited: 32
Kyoko Komai, Nicholas K. Kawasaki, Jason K. Higa, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1399-1399
Open Access | Times Cited: 32
Targeting ferroptosis: a novel insight against myocardial infarction and ischemia–reperfusion injuries
Xuejie Han, Jie Zhang, Jian Liu, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 108-123
Closed Access | Times Cited: 31
Xuejie Han, Jie Zhang, Jian Liu, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 108-123
Closed Access | Times Cited: 31
Ferroptosis and its role in skeletal muscle diseases
Ying Wang, Zepeng Zhang, Weikai Jiao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 29
Ying Wang, Zepeng Zhang, Weikai Jiao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 29
Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
Linxiang Zhou, Shangting Han, Jiayu Guo, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3653-3653
Open Access | Times Cited: 29
Linxiang Zhou, Shangting Han, Jiayu Guo, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3653-3653
Open Access | Times Cited: 29
Inflammation, dysregulated iron metabolism, and cardiovascular disease
Shaina L. Rosenblum
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 18
Shaina L. Rosenblum
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 18
Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway
Ya-Qian Jiang, Xiao-Yan Yang, Dan-Qing Duan, et al.
European Journal of Pharmacology (2023) Vol. 950, pp. 175774-175774
Closed Access | Times Cited: 18
Ya-Qian Jiang, Xiao-Yan Yang, Dan-Qing Duan, et al.
European Journal of Pharmacology (2023) Vol. 950, pp. 175774-175774
Closed Access | Times Cited: 18
Kinsenoside mitigates myocardial ischemia/reperfusion-induced ferroptosis via activation of the Akt/Nrf2/HO-1 pathway
Rong Wang, Siwei Dong, Rui Xia, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175985-175985
Closed Access | Times Cited: 18
Rong Wang, Siwei Dong, Rui Xia, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175985-175985
Closed Access | Times Cited: 18
Broadening horizons: The role of ferroptosis in myocardial ischemia–reperfusion injury
Ke Zhao, Xiaoshu Chen, Yu-Jing Bian, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 10, pp. 2269-2286
Closed Access | Times Cited: 16
Ke Zhao, Xiaoshu Chen, Yu-Jing Bian, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 10, pp. 2269-2286
Closed Access | Times Cited: 16
AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction
Ting Yang, Yang Qi, Qi Lai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115195-115195
Open Access | Times Cited: 15
Ting Yang, Yang Qi, Qi Lai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115195-115195
Open Access | Times Cited: 15
Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines
Weijing Lai, Bo Wang, Rongshuang Huang, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 22-34
Open Access | Times Cited: 5
Weijing Lai, Bo Wang, Rongshuang Huang, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 22-34
Open Access | Times Cited: 5
Melatonin inhibits ferroptosis through the ATF3/GPX4 signaling pathway to relieve myocardial ischemia–reperfusion injury in rats
Minjie He, Yongheng Yang, Xing He, et al.
In Vitro Cellular & Developmental Biology - Animal (2025)
Closed Access
Minjie He, Yongheng Yang, Xing He, et al.
In Vitro Cellular & Developmental Biology - Animal (2025)
Closed Access
Apelin13 Loaded Nano-Niosomes Confer Cardioprotection in a Rat Model of Myocardial Ischemia Reperfusion by Targeting the Nrf2/HO-1 Pathway
Neda Tekiyeh Maroof, Saeed Mehrzadi, Maryam Naseroleslami, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access
Neda Tekiyeh Maroof, Saeed Mehrzadi, Maryam Naseroleslami, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access
Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Feng Zhang, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
Qin Ru, Yusheng Li, Feng Zhang, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access